Article Details

PhoreMost: Biopharmaceutical Drug Target Company Raises $50 Million (Series B)

Retrieved on: 2024-09-16 23:29:22

Tags for this article:

Click the tags to see associated articles and topics

PhoreMost: Biopharmaceutical Drug Target Company Raises $50 Million (Series B). View article details on hiswai:

Excerpt

PhoreMost, a leading UK biopharmaceutical company unlocking the next generation of drug targets, announced it has added $12 million to its Series ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo